INNATE PHARMA (EPA:IPH) | WebDisclosure

Basculer en Français

10189	Companies
209749	Keywords
139909	Articles
111226	Press releases

Home
Companies
INNATE PHARMA

PRESS RELEASE

published on 01/16/2025 at 07:00, 1 year 2 months ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Innate Pharma publie le nouveau nombre d'actions et de droits de vote au 31 décembre 2024 conformément à la réglementation financière. Détails sur son capital social et ses projets d'immunothérapie contre le cancer

Droits De Vote Actions Immunothérapie Cancer Innate Pharma
PRESS RELEASE

published on 01/16/2025 at 07:00, 1 year 2 months ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Innate Pharma releases shares and voting rights update as of December 31, 2024, in compliance with regulations. Learn more about the global biotech company's innovative immunotherapies for cancer patients

Voting Rights Shares Biotechnology Immunotherapy Innate Pharma
BRIEF

published on 12/20/2024 at 07:05, 1 year 3 months ago

Innate Pharma à la 43ème J.P. Morgan Healthcare Conference

Investisseurs Présentation En Direct Immunothérapie Innate Pharma J.P. Morgan Conference
BRIEF

published on 12/20/2024 at 07:05, 1 year 3 months ago

Innate Pharma at the 43rd JP Morgan Healthcare Conference

Investors Immunotherapy Innate Pharma JP Morgan Conference Live Presentation
PRESS RELEASE

published on 12/20/2024 at 07:00, 1 year 3 months ago

Informations privilégiées / Autres communiqués
Innate Pharma annonce sa participation à la 43ème J.P. Morgan Healthcare Conference avec présentations de ses dirigeants. Focus sur les traitements d'immunothérapies contre le cancer

Cancer Innate Pharma Biotechnologies Immunothérapies J.P. Morgan Healthcare Conference
PRESS RELEASE

published on 12/20/2024 at 07:00, 1 year 3 months ago

Inside Information / Other news releases
Innate Pharma to participate in the 43rd Annual J.P. Morgan Healthcare Conference with CEO Jonathan Dickinson and other executives presenting. Company focuses on developing immunotherapies for cancer patients

Biotechnology Innate Pharma Immunothérapies Cancer Patients J.P. Morgan Healthcare Conference
BRIEF

published on 12/06/2024 at 07:05, 1 year 4 months ago

Innate Pharma : Investissement de 7,9 millions de dollars pour IPH6501

Investissement Essai Clinique Innate Pharma Lymphome Folliculaire IPH6501
BRIEF

published on 12/06/2024 at 07:05, 1 year 4 months ago

Innate Pharma: Investment of 7.9 million dollars for IPH6501

Investment Clinical Trial Innate Pharma IPH6501 Follicular Lymphoma
PRESS RELEASE

published on 12/06/2024 at 07:00, 1 year 4 months ago

Informations privilégiées / Autres communiqués
Innate Pharma et l'Institut d'Innovation pour le Lymphome Folliculaire (IFLI) signent un accord d'investissement jusqu'à 7,9 millions de dollars pour le développement d'IPH6501 dans le lymphome folliculaire

Investissement Innate Pharma Lymphome Folliculaire IPH6501 IFLI
BRIEF

published on 11/20/2024 at 07:05, 1 year 4 months ago

Innate Pharma dévoile son calendrier financier pour 2025

Résultats Annuels Innate Pharma Calendrier Financier 2025 Assemblées Et Publications Cotisation Euronext Et Nasdaq

Accesswire

Published on 04/11/2026 at 02:00, 23 hours 50 minutes ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 04/11/2026 at 01:40, 1 day ago

Arctic Fox Announces Closing of Final Tranche Of Non-Brokered Private Placement
Published on 04/11/2026 at 00:30, 1 day 1 hour ago

Trans Canada Gold Corp. Announces Proposed Warrant Extension
Published on 04/10/2026 at 23:30, 1 day 2 hours ago

Clean Air Metals Announces Management Changes
Published on 04/10/2026 at 23:15, 1 day 2 hours ago

Gemdale Announces Change of Corporate Secretary

View all ACCESSWIRE

EQS Group

Published on 04/11/2026 at 16:45, 9 hours 5 minutes ago

CGTN: One family: Xi Jinping stresses keeping future of cross-Strait ties in Chinese hands
Published on 04/11/2026 at 16:40, 9 hours 10 minutes ago

VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe
Published on 04/11/2026 at 16:30, 9 hours 20 minutes ago

VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany
Published on 04/10/2026 at 19:00, 1 day 6 hours ago

EPIC Suisse AG – Annual General Meeting 2026 approves all proposals by the Board of Directors
Published on 04/10/2026 at 18:30, 1 day 7 hours ago

AGM 2026 - Bossard Holding AG Press Release

Les Echos

Published on 04/11/2026 at 16:29, 9 hours 21 minutes ago

Décès de Madame Jacqueline Himsworth, Présidente du Conseil d’administration de Manitou Group
Published on 04/11/2026 at 16:29, 9 hours 21 minutes ago

Passing of Madame Jacqueline Himsworth, Chairman of the Board of Directors of Manitou Group
Published on 04/10/2026 at 18:35, 1 day 7 hours ago

Disclosure of trading own shares
Published on 04/10/2026 at 18:35, 1 day 7 hours ago

Déclaration des transactions sur actions propres
Published on 04/10/2026 at 18:26, 1 day 7 hours ago

EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE

View all LES ECHOS COMFI WIRE